We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Augmedix Inc (AUGX) USD0.0001

Sell:$3.75 Buy:$4.41 Change: $0.05 (1.31%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
Sell:$3.75
Buy:$4.41
Change: $0.05 (1.31%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
Sell:$3.75
Buy:$4.41
Change: $0.05 (1.31%)
Market closed |  Prices as at close on 15 April 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patient’s health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.

Contact details

Address:
111 Sutter Street, Suite 1300
SAN FRANCISCO
94104
United States
Telephone:
+1 (561) 9892208
Website:
https://augmedix.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AUGX
ISIN:
US05105P1075
Market cap:
$185.70 million
Shares in issue:
48.74 million
Sector:
Health Care Technology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Emmanuel Krakaris
    President, Chief Executive Officer, Company Secretary, Director
  • Ian Shakil
    Founder, Director, Founder, Chief Strategy Officer
  • Paul Ginocchio
    Chief Financial Officer
  • Sandra Breber
    Chief Operating Officer
  • Tomer Levy
    Senior Vice President of Engineering
  • Saurav Chatterjee
    Chief Technology Officer
  • Jonathan Hawkins
    Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.